1. Home
  2. CERS vs NRIM Comparison

CERS vs NRIM Comparison

Compare CERS & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • NRIM
  • Stock Information
  • Founded
  • CERS 1991
  • NRIM 1990
  • Country
  • CERS United States
  • NRIM United States
  • Employees
  • CERS N/A
  • NRIM N/A
  • Industry
  • CERS EDP Services
  • NRIM Savings Institutions
  • Sector
  • CERS Technology
  • NRIM Finance
  • Exchange
  • CERS Nasdaq
  • NRIM Nasdaq
  • Market Cap
  • CERS 324.3M
  • NRIM 369.8M
  • IPO Year
  • CERS 1997
  • NRIM N/A
  • Fundamental
  • Price
  • CERS $1.70
  • NRIM $83.53
  • Analyst Decision
  • CERS Buy
  • NRIM
  • Analyst Count
  • CERS 3
  • NRIM 0
  • Target Price
  • CERS $3.17
  • NRIM N/A
  • AVG Volume (30 Days)
  • CERS 1.9M
  • NRIM 24.0K
  • Earning Date
  • CERS 10-30-2024
  • NRIM 10-23-2024
  • Dividend Yield
  • CERS N/A
  • NRIM 3.04%
  • EPS Growth
  • CERS N/A
  • NRIM 22.45
  • EPS
  • CERS N/A
  • NRIM 5.86
  • Revenue
  • CERS $176,229,000.00
  • NRIM $141,590,000.00
  • Revenue This Year
  • CERS $26.47
  • NRIM N/A
  • Revenue Next Year
  • CERS $11.48
  • NRIM $3.03
  • P/E Ratio
  • CERS N/A
  • NRIM $13.90
  • Revenue Growth
  • CERS 14.71
  • NRIM 12.70
  • 52 Week Low
  • CERS $1.38
  • NRIM $43.92
  • 52 Week High
  • CERS $2.59
  • NRIM $85.06
  • Technical
  • Relative Strength Index (RSI)
  • CERS 46.20
  • NRIM 65.28
  • Support Level
  • CERS $1.63
  • NRIM $79.58
  • Resistance Level
  • CERS $2.03
  • NRIM $85.06
  • Average True Range (ATR)
  • CERS 0.11
  • NRIM 2.71
  • MACD
  • CERS -0.01
  • NRIM 0.98
  • Stochastic Oscillator
  • CERS 31.37
  • NRIM 84.80

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About NRIM Northrim BanCorp Inc

Northrim BanCorp Inc is a bank holding company. The company operates in two segments: Community Banking and Home Mortgage Lending. It generates maximum revenue from the Community Banking segment. It offers to spend and save products such as checking, savings, money market accounts, debit cards, cashback rewards, and credit cards. It also includes loans and credit lines, mortgage loans, investment, and plan products.

Share on Social Networks: